{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The disease, if it is a disease, afflicts most middle-aged and elderly women, and a large segment of men. But it has no symptoms, it is not clear what patients should do about it and it is being diagnosed more and more often. The condition is osteopenia, or low bone density. It is considered by many doctors to be a first step along the path to osteoporosis, a serious condition in which bone density is extremely low and bones are porous and prone to shatter. But researchers say that while bone density predicts fracture risk, more is involved, including age, family history and a poorly understood factor known as bone quality.", "headline": {"main": "Bone Diagnosis Gives New Data But No Answers"}, "abstract": "Osteopenia, or low bone density, considered by many doctors to be first step along path to osteoporisis, serious condition in which bone density is extremely low and bones are porous and prone to shatter, is being increasingly diagnosed; condition has no symptoms and it its unclear what patients should do about it; problem is example of what happens when screening gets ahead of treatment, or even understanding of condition; stakes are particularly high because number of patients is huge; photos (M)", "print_page": "1", "word_count": 1714, "_id": "4fd296a48eb7c8105d87279c", "snippet": "The disease, if it is a disease, afflicts most middle-aged and elderly women, and a large segment of men. But it has no symptoms, it is not clear what patients should do about it and it is being diagnosed more and more often.    The condition is...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/09/28/us/bone-diagnosis-gives-new-data-but-no-answers.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "BONES"}, {"name": "subject", "value": "TESTS AND TESTING"}, {"name": "subject", "value": "OSTEOPOROSIS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "2003-09-28T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Interview", "blog": [], "news_desk": "Science Desk", "lead_paragraph": "In the late 1970's, Dr. Sheldon Krimsky was a young assistant professor at Tufts -- politically na\u00efve, by his own admission -- when he was asked to lead a team of students investigating whether a chemical company had polluted water wells in a nearby town. When the company, W. R. Grace, learned that Dr. Krimsky and his students would soon be releasing a report that it would not like, a top executive visited the president of the university to ask him to stop its publication, Dr. Krimsky says in a new book. (The company says it cannot offer a perspective on the account because it was so long ago.)", "headline": {"main": "Uncoupling Campus and Company", "kicker": "A CONVERSATION WITH: SHELDON KRIMSKY"}, "abstract": "Dr Sheldon Krimsky, who has recently written book Science in Private Interest, is interviewed and gives his thoughts on growing relationship between universities and colleges and private sector; explains how scientists used to view discoveries as contributions to public interest, not as financial opportunities; defines effect of funding on science and explores how data can be skewed to support private interests at expense of consumer safety and information; photo (M)", "print_page": "2", "word_count": 1223, "_id": "4fd277258eb7c8105d83853a", "snippet": "In the late 1970's, Dr. Sheldon Krimsky was a young assistant professor at Tufts -- politically na\u00efve, by his own admission -- when he was asked to lead a team of students investigating whether a chemical company had polluted water wells in a nearby...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/09/23/science/a-conversation-with-sheldon-krimsky-uncoupling-campus-and-company.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "SCIENCE IN THE PRIVATE INTEREST (BOOK)"}, {"name": "persons", "value": "KRIMSKY, SHELDON"}, {"name": "subject", "value": "FINANCES"}, {"name": "subject", "value": "COLLEGES AND UNIVERSITIES"}, {"name": "subject", "value": "BOOKS AND LITERATURE"}, {"name": "subject", "value": "SCIENCE AND TECHNOLOGY"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "BUDGETS AND BUDGETING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2003-09-23T00:00:00Z", "section_name": "Technology; Science; Education; Health; Books"}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Last week, the United Automobile Workers offered more concessions to the Big Three than it has in the last two decades of contract talks. Then again, concessions have not really been a feature of the last two decades of contract talks in the American auto industry. While auto workers see a contract that extends a lifeline to the struggling Big Three, Wall Street sees baby steps that amount to a glass half-full in some minds and fully empty in others.", "headline": {"main": "Auto Deal or Bust"}, "abstract": "Analysis contract agreements between Big Three automobile manufacturers and UAW workers; says while auto workers see contract that extends lifeline to struggling Big Three, Wall Street sees baby steps that amount to glass half-full in some minds and fully empty in others (M)", "print_page": "2", "word_count": 1079, "_id": "4fd277258eb7c8105d838539", "snippet": "Last week, the United Automobile Workers offered more concessions to the Big Three than it has in the last two decades of contract talks. Then again, concessions have not really been a feature of the last two decades of contract talks in the American...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/09/23/business/auto-deal-or-bust.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "UNITED AUTOMOBILE WORKERS"}, {"name": "organizations", "value": "GENERAL MOTORS CORP"}, {"name": "organizations", "value": "FORD MOTOR CO"}, {"name": "organizations", "value": "DAIMLERCHRYSLER AG"}, {"name": "subject", "value": "AUTOMOBILES"}, {"name": "subject", "value": "LABOR"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Danny", "lastname": "HAKIM"}], "original": "By DANNY HAKIM"}, "document_type": "article", "pub_date": "2003-09-23T00:00:00Z", "section_name": "Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Researchers in Iceland say they have discovered the first gene that underlies common forms of stroke, a disease that affects more than 600,000 people a year in the United States. People with a particular version of the gene have a three to five times greater risk of stroke, said the researchers, who are at Decode Genetics, a company based in Reykjavik. This is as large as or larger than known environmental risk factors like high blood pressure, high cholesterol and smoking.", "headline": {"main": "Scientists in Iceland Discover First Gene Tied to Stroke Risk"}, "abstract": "Researchers in Iceland say they have discovered first gene that underlies common forms of stroke, disease that affects more than 600,000 people a year in United States; say people with particular version of gene have three to five times greater risk of stroke; this is as large as or larger than known environmental risk factors like high blood pressure, high cholesterol and smoking; Dr Kari Stefansson of Decode Genetics, company doing research, says new gene makes enzyme that is good target for drugs, and Roche pharmaceutical company in Switzerland is already testing several such drugs in laboratory rats; new gene had not previously been implicated in stroke; its detection may open new insights into mechanisms of disease; Decode's work is reported in journal Nature Genetics; Dr Jonathan Rosand, American stroke specialist, hails finding but cautions that study is unlikely to yield new treatments any time soon and needs to be confirmed by other researchers in other populations (M)", "print_page": "1", "word_count": 1027, "_id": "4fd2771c8eb7c8105d838074", "snippet": "Researchers in Iceland say they have discovered the first gene that underlies common forms of stroke, a disease that affects more than 600,000 people a year in the United States.    People with a particular version of the gene have a three to five...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2003/09/22/us/scientists-in-iceland-discover-first-gene-tied-to-stroke-risk.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "STEFANSSON, KARI"}, {"name": "persons", "value": "ROSAND, JONATHAN"}, {"name": "glocations", "value": "ICELAND"}, {"name": "organizations", "value": "ROCHE AG"}, {"name": "organizations", "value": "NATURE GENETICS"}, {"name": "organizations", "value": "DECODE GENETICS"}, {"name": "subject", "value": "STROKE"}, {"name": "subject", "value": "GENETICS AND HEREDITY"}, {"name": "subject", "value": "RATS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "BLOOD PRESSURE"}, {"name": "subject", "value": "SMOKING AND TOBACCO"}, {"name": "subject", "value": "CHOLESTEROL"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Nicholas", "lastname": "WADE"}], "original": "By NICHOLAS WADE"}, "document_type": "article", "pub_date": "2003-09-22T00:00:00Z", "section_name": "Front Page; Health; U.S."}], "meta": {"hits": 4, "offset": 0, "time": 38}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}